Actuate Share Price

Actuate Share Price

NASDAQ: ACTU | Micro Cap | Healthcare
$0.26
+$0.01 (4.58%) Last updated on 19 Nov, 2026 | 02:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Actuate Stock Performance

Open
$0.29
Prev. Close
$0.25
Circuit Range
N/A
Day Range
$0.25 - $0.29
Year Range
$0.24 - $7.80
Volume
2,164
Average Traded
$0.26

Actuate Share Price Today

As of 19 November 2026, Actuate Therapeutics, Inc.'s share price is $0.26. The stock opened at $0.29, compared to its previous close of $0.25. During today's trading session, Actuate Therapeutics, Inc.'s share price traded between $0.25 and $0.29, with an average price of $0.27. Over the past 52 weeks, the stock has recorded a high of $7.80 and a low of $0.24. In terms of performance, Actuate Therapeutics, Inc.'s share price has declined by 86.99% over the last six months and is down 96.52% on a year-on-year basis.

Actuate Share Price Chart

Line chart of the Actuate price trend over the selected period. The price rose overall, ranging from 0.25 to 0.31, ending at 0.26.
$0.25$0.29
L
Show Current Price
H

Actuate Stock Fundamentals & Key Indicators

Market Cap
$5.52M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.34
Revenue (TTM)
$0.00
Return On Equity (TTM)
2282.79%
Profit Margin
N/A
Debt to Equity
-0.50
Quarterly Earnings Growth YoY
24.84%

Actuate Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.55-$5.63-$4.87-$3.42
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-23.74%13.50%29.77%

Actuate Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$27.29-$22.23
Net Profit MarginN/AN/A
Income ChangeN/A18.54%

Actuate Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets0.390.11
Current Assets13.649.21
Total Assets14.049.32
Non Current Liabilities0.40.41
Current Liabilities5.718.8
Total Liabilities6.119.21
Shareholders' Equity7.920.1

Actuate Cash Flow

Annually
Particulars20252024
Operating (USD Million)-19.21-21.84
Investing (USD Billion)0.00.0
Financing (USD Million)23.7227.53

About Actuate

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Actuate Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.36
$0.26
-23.88%
Oct 2026
$0.86
$0.34
-57.81%
Sep 2026
$1.45
$0.79
-53.84%
Aug 2026
$1.12
$1.72
+54.26%
Jul 2026
$1.50
$1.11
-25.67%
Jun 2026
$2.21
$1.50
-25.74%
May 2026
$3.10
$2.02
-30.58%
Apr 2026
$2.83
$2.91
+6.99%
Mar 2026
$3.60
$2.72
-28.42%
Feb 2026
$4.92
$3.80
-19.83%
Jan 2026
$6.01
$4.74
-22.30%
Dec 2025
$7.23
$6.10
-19.21%

Actuate Share Price FAQs